Compare PXS & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PXS | BTMD |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7M | 39.0M |
| IPO Year | 2015 | 2021 |
| Metric | PXS | BTMD |
|---|---|---|
| Price | $7.78 | $1.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.61 |
| AVG Volume (30 Days) | ★ 132.9K | 132.5K |
| Earning Date | 11-19-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | $21.40 | N/A |
| Revenue Next Year | $23.60 | $5.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.56 | $1.06 |
| 52 Week High | $8.30 | $3.26 |
| Indicator | PXS | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 63.29 | 37.17 |
| Support Level | $6.30 | N/A |
| Resistance Level | $8.30 | $1.68 |
| Average True Range (ATR) | 0.44 | 0.08 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 73.44 | 40.00 |
Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.